The coronavirus crisis has upended the status quo in all kinds of ways, and that includes how clinical trials are run.
Nearly $2 billion poured into companies touting advancements in healthcare AI in 2019. Investments in the first quarter of 2020 totaled $635 million, up from $155 million in the first quarter of 2019, according to digital health technology funderAt least three healthcare AI technology companies have made funding deals specific to the COVID-19 crisis, includingOverall, AI’s implementation in everyday clinical care is less common than hype over the technology would suggest.
AI has advanced further in imaging than in other areas of clinical medicine because radiological images have tons of data for algorithms to process, and more data makes the programs more effective, Longhurst said. But while AI specialists have tried to get AI to do things like predict sepsis and acute respiratory distress — researchers at Johns Hopkins University
KTLA 'Artificial intelligence' huh? So they enlisted the TIMES to help.
KTLA More fear mongering bullshit Agenda21
KTLA
KTLA We already have a weapon to defeat it. It's called Hydroxychloroquine